Showing results (1171-1180 of 1,612) with videos related to
Sort By:
Pageof 162
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsT Le Chevalier, D Brisgand, J Y Douillard, et al.Clinical and Experimental Immunology|May 27, 2016
Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infectionsA N Hasan, A Selvakumar, E Shabrova, et al.American Journal of Veterinary Research|May 27, 2016
Pharmacokinetics and tissue elimination of flunixin in veal calvesLindsey W Kissell, Patrick D Brinson, Ronette Gehring, et al.Expert Opinion on Drug Metabolism & Toxicology|February 1, 2024
In-silico approaches to assessing multiple high-level drug-drug and drug-disease adverse drug effectsXuan Xu, Jim E Riviere, Shahzad Raza, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 28, 2023
Development and application of an interactive generic physiologically based pharmacokinetic (igPBPK) model for adult beef cattle and lactating dairy cows to estimate tissue distribution and edible tissue and milk withdrawal intervals for per- and polyfluoroalkyl substances (PFAS)Wei-Chun Chou, Lisa A Tell, Ronald E Baynes, et al.Journal of Vascular Surgery. Venous and Lymphatic Disorders|November 28, 2020
Timing and characteristics of venous thromboembolism after noncancer surgeryManuela Expósito-Ruiz, Juan Ignacio Arcelus, Joseph A Caprini, et al.Journal of Clinical Pharmacology|January 25, 2006
Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver functionJohn M Kovarik, Robert L Schmouder, Stefan Hartmann, et al.Journal of Inorganic Biochemistry|October 26, 1999
Copper(II) complexes of a nonsteroidal anti-inflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-mu-(2-[3-(trifluoromethyl) phenyl]aminonicotinato)bis(dimethylsulfoxide)-dicopper(II) complex at 190 K. Anti-inflammatory propertiesF T Greenaway, E Riviere, J J Girerd, et al.Journal of Veterinary Pharmacology and Therapeutics|March 22, 2014
Prediction of formulation effects on dermal absorption of topically applied ectoparasiticides dosed in vitro on canine and porcine skin using a mixture-adjusted quantitative structure permeability relationshipJ E Riviere, J D Brooks, W T Collard, et al.Journal of Internal Medicine|August 9, 2019
D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registryO Avnery, M Martin, A Bura-Riviere, et al.Pageof 162